We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Draft Plan Outlines New ‘Benefit-Risk Framework’ for Reviews
FDA Draft Plan Outlines New ‘Benefit-Risk Framework’ for Reviews
March 8, 2013
The FDA has issued its draft plan for implementing standard benefit-risk templates in drug reviews — a PDUFA V commitment that responds to stakeholder calls for more clarity and transparency in approval decisions.